Clinical and Molecular Study of Common Thrombophilia Mutation Prothrombin G20210A

Antonia Angelopoulou; Dimitriοs Vlachakis; George Chrousos; Nikolaos Cosmidis; Christos Yapijakis

doi:10.1007/978-3-030-78787-5_40

Related publications

Chapter in a book2026

Clinical, Molecular and Bioinformatic Study of Common Thrombophilia Mutation Factor V Leiden

Antonia Angelopoulou, Eleni Papakonstantinou, Dimitriοs Vlachakis, George Chrousos, Nikolaos Cosmidis, Christos Yapijakis

Chapter in a book2025

Clinical, Molecular, and Bioinformatic Study of Common Thrombophilia Mutation Factor V Leiden

Antonia Angelopoulou, Eleni Papakonstantinou, Dimitriοs Vlachakis, George Chrousos, Nikolaos Cosmidis, Christos Yapijakis

Article2004

No effect of the prothrombin G20210A mutation on protein C activation in a large kindred with type I protein C deficiency

Carla Y. Vossen, Karin Strandberg, Johan Stenflo, Frits R. Rosendaal, Peter Callas, George L. Long, Edwin G. Bovill

Blood Coagulation & Fibrinolysis

Article2002

Factor V leiden, prothrombin g20210a, and risk of sudden coronary death in apparently healthy persons

Alexander P. Reiner, Frits R. Rosendaal, Pieter H. Reitsma, Rozenn N. Lemaître, Rachel M. Pearce, Yechiel Friedlander, Trivellore E. Raghunathan, Bruce M. Psaty, David S. Siscovick

The American Journal of Cardiology

Article1998

Risk of Stroke in Young Women and Two Prothrombotic Mutations: Factor V Leiden and Prothrombin Gene Variant (G20210A)

W.T. Longstreth, Frits R. Rosendaal, David S. Siscovick, Hans L. Vos, Stephen M. Schwartz, Bruce M. Psaty, T. E. Raghunathan, Thomas D. Koepsell, P.H. Reitsma

Stroke